Y020-8717 Screening compound: N~1~-(1,3-benzodioxol-5-yl)-2-[2-oxo-1-(3-pyridylmethyl)-2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-3-yl]acetamide

Y020-8717 Screening compound: N~1~-(1,3-benzodioxol-5-yl)-2-[2-oxo-1-(3-pyridylmethyl)-2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-3-yl]acetamide
Y020-8717 Screening compound: N~1~-(1,3-benzodioxol-5-yl)-2-[2-oxo-1-(3-pyridylmethyl)-2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-3-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y020-8717
N~1~-(1,3-benzodioxol-5-yl)-2-[2-oxo-1-(3-pyridylmethyl)-2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-3-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y020-8717

Molecular Formula

C24H19N5O4 (C24 H19 N5 O4)

Compound Name

N~1~-(1,3-benzodioxol-5-yl)-2-[2-oxo-1-(3-pyridylmethyl)-2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-3-yl]acetamide

IUPAC name

N-(2H-13-benzodioxol-5-yl)-2-{4-oxo-5-[(pyridin-3-yl)methyl]-257-triazatricyclo[6.4.0.0^{26}]dodeca-1(8)6911-tetraen-3-yl}acetamide

SMILES

O=C(CC(C(N1Cc2cnccc2)=O)n2c1nc1c2cccc1)Nc(cc1)cc2c1OCO2

InChI

InChI=1S/C24H19N5O4/c30-22(26-16-7-8-20-21(10-16)33-14-32-20)11-19-23(31)28(13-15-4-3-9-25-12-15)24-27-17-5-1-2-6-18(17)29(19)24/h1-10,12,19H,11,13-14H2,(H,26,30)/t19-/m0/s1

InChI Key

WTBFPXDDCZTQSX-IBGZPJMESA-N

MDL Number (MFCD)

MFCD11082290

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

441.45

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.720

Distribution Coefficient, logD

2.688

Water Solubility, LogSw

-3.00

Polar Surface Area

75.921

Acid Dissociation Constant (pKa)

8.64

Base Dissociation Constant (pKb)

5.60

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

16.70

Y020-8717 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

DGK Inhibitors Library (10558 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with Y020-8717 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y020-8717?
Check Price and Availability of Y020-8717, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y020-8717 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y020-8717
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y020-8717
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y020-8717 available by request